Here’s a breakdown of the key data from the provided text,organized for clarity:
Key News: Mu Medical Emerges from Partnership
* Nanodropper,Bedo Solutions,and Viseon Labs have merged to form Mu Medical. This new company will focus on a precision eye care platform.
* The companies came together due to a “shared clinical beliefs” and a desire to address both clinical decision-making and patient adherence as linked issues.
* The goal is to support patients throughout their entire eye care routine, not just with a single device.
Leadership Roles in Mu Medical:
* Allisa Song, MD (founder and CEO of nanodropper) will be CEO and board chair of Mu Medical.
* Sina Fateh will be chief strategy officer and board observer.
* Robert Kinast, MD will be board observer and medical adviser.
Company Backgrounds & Focus:
* Nanodropper: Known for its device to help with precise eye drop delivery.
* Bedo Solutions: Focuses on supporting patients’ daily eye care routines, including accurate dosing and adherence.
* Viseon labs: Founded by Sina Fateh, details on its specific focus are not provided in this excerpt.
Contact Information:
* Sina Fateh, MD: sina@myopiaai.com
* Robert Kinast, MD: robertkinast@gmail.com
* Mu Medical: mackenzie@nanodropper.com
Source & Disclosures:
* source: Press Release (https://www.prnewswire.com/news-releases/nanodropper-now-operating-as-mu-medical-planned-expansion-of-precision-eyecare-platform-with-bedo-solutions-and-viseon-labs-302657557.html)
* Disclosures: Fateh is founder/CEO of viseon Labs. Kinast is founder/CEO of Bedo Solutions.
Additional Information:
* The article is published by Primary Care Optometry News on Healio.
* There is a promotional widget for “Healio AI,” a clinical question answering tool.
* There’s also a call to action to subscribe to email alerts for this topic.
